Phase
Condition
Congestive Heart Failure
Chest Pain
Hyponatremia
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age of 18 years or older
Capable of understanding and signing informed consent
A diagnosis of HFpEF according to the HFA-PEFF diagnostic algorithm of the ESCor/and a high (90%) probability of HFpEF according to the H2FPEF score, i.e. a scoreof 6 or higher.
Exclusion
Exclusion Criteria:
History of LVEF ≤40%
Scheduled for surgery or intervention for both coronary and non-coronary indicationwithin 6 months of inclusion
Impaired renal function, defined as eGFR < 20 mL/min/1.73 m2 (CKD-EPI) or requiringdialysis at the time of screening
Acute or chronic liver disease, defined by serum levels of transaminases or alkalinephosphatase more than three times the upper limit of normal at screening
COPD Gold stage IV
Congenital heart disease
Pregnancy
Coexistent condition with life expectancy of <1 year
Unlikely to appear at all scheduled follow-up visits
Linguistic barrier
Study Design
Study Description
Connect with a study center
Noordwest Ziekenhuisgroep
Alkmaar, Noord-Holland 1815JD
NetherlandsActive - Recruiting
Amsterdam UMC
Amsterdam, Noord-Holland 1081HV
NetherlandsActive - Recruiting
OLVG Ziekenhuis
Amsterdam, Noord-Holland 1091AC
NetherlandsActive - Recruiting
Erasmus MC
Rotterdam, Zuid-Holland 3015GD
NetherlandsActive - Recruiting
Franciscus Gasthuis & Vlietland Ziekenhuis
Rotterdam, Zuid-Holland 3004BA
NetherlandsActive - Recruiting
Ikazia Ziekenhuis
Rotterdam, Zuid-Holland 3083AN
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.